Examining Symptom Management and Quality of Life of Loop Diuretic-Induced Overactive Bladder Among Heart Failure Patients: Physician and Patient Perspectives
Loop diuretics are strongly recommended in patients with chronic congestive heart failure (HF) to alleviate signs and symptoms of fluid overload. Loop diuretics help relieve congestive symptoms and reduce mortality, but may have side effects. This survey study examined the impact of loop diuretic-in...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-02-01
|
Series: | Journal of Patient Experience |
Online Access: | https://doi.org/10.1177/23743735251316416 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832086635539333120 |
---|---|
author | Xin Pan PharmD, MPH Christopher S Wilcox MD, PhD Bertram Pitt MD Salim Shah MPhil, PhD Anandi V Law B.Pharm., MS, PhD, FAPhA |
author_facet | Xin Pan PharmD, MPH Christopher S Wilcox MD, PhD Bertram Pitt MD Salim Shah MPhil, PhD Anandi V Law B.Pharm., MS, PhD, FAPhA |
author_sort | Xin Pan PharmD, MPH |
collection | DOAJ |
description | Loop diuretics are strongly recommended in patients with chronic congestive heart failure (HF) to alleviate signs and symptoms of fluid overload. Loop diuretics help relieve congestive symptoms and reduce mortality, but may have side effects. This survey study examined the impact of loop diuretic-induced overactive bladder (LD-OAB) symptoms on quality of life (QOL) in HF patients; and management of OAB by HF patients and physicians. We found that (1) HF patients noted less severity of symptoms but similar QOL with non-HF. (2) HF patients (58.8%) self-managed and underreported symptoms to physicians compared to non-HF (74.8%); accordingly 65% of physicians noticed and managed symptoms. (3) Patients used mechanical solutions (pads/diapers, Kegel exercises, and fluid reduction), and physicians adjusted diuretic doses or prescribed medications for OAB. Our study highlighted that HF patients' QOL associated with bladder symptoms was not better than the non-HF group despite milder symptoms. Many HF patients either did not report or coped with/self-managed their loop diuretic-induced bladder symptoms, pointing to a need for better awareness of patient experiences and patient-physician communication. |
format | Article |
id | doaj-art-36628eda9900424e9d0d439cb44ad759 |
institution | Kabale University |
issn | 2374-3743 |
language | English |
publishDate | 2025-02-01 |
publisher | SAGE Publishing |
record_format | Article |
series | Journal of Patient Experience |
spelling | doaj-art-36628eda9900424e9d0d439cb44ad7592025-02-06T10:03:20ZengSAGE PublishingJournal of Patient Experience2374-37432025-02-011210.1177/23743735251316416Examining Symptom Management and Quality of Life of Loop Diuretic-Induced Overactive Bladder Among Heart Failure Patients: Physician and Patient PerspectivesXin Pan PharmD, MPH0Christopher S Wilcox MD, PhD1Bertram Pitt MD2Salim Shah MPhil, PhD3Anandi V Law B.Pharm., MS, PhD, FAPhA4 Department of Pharmacy Practice and Administration, College of Pharmacy, Western University of Health Sciences, Pomona, CA, USA Division of Nephrology and Hypertension and Hypertension Center, Georgetown University, Washington, DC, USA Department of Internal Medicine, Division of Cardiology, University of Michigan School of Medicine, Ann Arbor, MI, USA Sarfez Pharmaceuticals Inc., Vienna, VA, USA Department of Pharmacy Practice and Administration, College of Pharmacy, Western University of Health Sciences, Pomona, CA, USALoop diuretics are strongly recommended in patients with chronic congestive heart failure (HF) to alleviate signs and symptoms of fluid overload. Loop diuretics help relieve congestive symptoms and reduce mortality, but may have side effects. This survey study examined the impact of loop diuretic-induced overactive bladder (LD-OAB) symptoms on quality of life (QOL) in HF patients; and management of OAB by HF patients and physicians. We found that (1) HF patients noted less severity of symptoms but similar QOL with non-HF. (2) HF patients (58.8%) self-managed and underreported symptoms to physicians compared to non-HF (74.8%); accordingly 65% of physicians noticed and managed symptoms. (3) Patients used mechanical solutions (pads/diapers, Kegel exercises, and fluid reduction), and physicians adjusted diuretic doses or prescribed medications for OAB. Our study highlighted that HF patients' QOL associated with bladder symptoms was not better than the non-HF group despite milder symptoms. Many HF patients either did not report or coped with/self-managed their loop diuretic-induced bladder symptoms, pointing to a need for better awareness of patient experiences and patient-physician communication.https://doi.org/10.1177/23743735251316416 |
spellingShingle | Xin Pan PharmD, MPH Christopher S Wilcox MD, PhD Bertram Pitt MD Salim Shah MPhil, PhD Anandi V Law B.Pharm., MS, PhD, FAPhA Examining Symptom Management and Quality of Life of Loop Diuretic-Induced Overactive Bladder Among Heart Failure Patients: Physician and Patient Perspectives Journal of Patient Experience |
title | Examining Symptom Management and Quality of Life of Loop Diuretic-Induced Overactive Bladder Among Heart Failure Patients: Physician and Patient Perspectives |
title_full | Examining Symptom Management and Quality of Life of Loop Diuretic-Induced Overactive Bladder Among Heart Failure Patients: Physician and Patient Perspectives |
title_fullStr | Examining Symptom Management and Quality of Life of Loop Diuretic-Induced Overactive Bladder Among Heart Failure Patients: Physician and Patient Perspectives |
title_full_unstemmed | Examining Symptom Management and Quality of Life of Loop Diuretic-Induced Overactive Bladder Among Heart Failure Patients: Physician and Patient Perspectives |
title_short | Examining Symptom Management and Quality of Life of Loop Diuretic-Induced Overactive Bladder Among Heart Failure Patients: Physician and Patient Perspectives |
title_sort | examining symptom management and quality of life of loop diuretic induced overactive bladder among heart failure patients physician and patient perspectives |
url | https://doi.org/10.1177/23743735251316416 |
work_keys_str_mv | AT xinpanpharmdmph examiningsymptommanagementandqualityoflifeofloopdiureticinducedoveractivebladderamongheartfailurepatientsphysicianandpatientperspectives AT christopherswilcoxmdphd examiningsymptommanagementandqualityoflifeofloopdiureticinducedoveractivebladderamongheartfailurepatientsphysicianandpatientperspectives AT bertrampittmd examiningsymptommanagementandqualityoflifeofloopdiureticinducedoveractivebladderamongheartfailurepatientsphysicianandpatientperspectives AT salimshahmphilphd examiningsymptommanagementandqualityoflifeofloopdiureticinducedoveractivebladderamongheartfailurepatientsphysicianandpatientperspectives AT anandivlawbpharmmsphdfapha examiningsymptommanagementandqualityoflifeofloopdiureticinducedoveractivebladderamongheartfailurepatientsphysicianandpatientperspectives |